Gene · 6091
Papers2,184
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,184
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXC4 promotes proliferation of endometriotic stromal cells via the SLIT2-ROBO1 axis. | Mol Hum Reprod | 2025 | 40714816 | PubTator, text mining | PubMed |
| Dissecting the biology of gliomagenesis: Evaluating the interaction between IDH tumor mutation and germline variants. | Neurooncol Adv | 2025 | 40709013 | PubTator, text mining | PubMed |
| [Clinical significance of SLIT2/ROBO1 expression in prostate cancer]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 40619262 | PubTator, text mining | PubMed |
| SLIT/ROBO Pathway and Prostate Cancer: Gene and Protein Expression and Their Prognostic Values. | Int J Mol Sci | 2025 | 40508075 | PubTator, text mining | PubMed |
| Transcriptomic analysis of the m6A reader YTHDF2 in the maintenance and differentiation of human embryonic stem cells. | Stem Cells | 2025 | 40418739 | PubTator, text mining | PubMed |
| Distinct genetic alterations in CD10-negative MUM1-positive follicular lymphoma. | Pathology | 2025 | 40393874 | PubTator, text mining | PubMed |
| Optimization and development of a high-throughput TR-FRET screening assay for SLIT2/ROBO1 interaction. | SLAS Discov | 2025 | 40393541 | PubTator, text mining | PubMed |
| From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies. | Transl Cancer Res | 2025 | 40386273 | PubTator, text mining | PubMed |
| Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations. | Blood Adv | 2025 | 40367415 | PubTator, text mining | PubMed |
| ROBO1 enhanced esophageal carcinoma cell radioresistance through accelerating G3BP2-mediated eIF3A degradation. | Cell Death Dis | 2025 | 40188129 | PubTator, text mining | PubMed |
| Expanding ligand-receptor interaction networks for axon guidance: Structural insights into signal crosstalk and specificity. | Curr Opin Neurobiol | 2025 | 40117944 | PubTator, text mining | PubMed |
| Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients. | Int J Mol Sci | 2025 | 40076777 | PubTator, text mining | PubMed |
| The microcephaly-associated transcriptional regulator AUTS2 cooperates with Polycomb complex PRC2 to produce upper-layer neurons in mice. | EMBO J | 2025 | 39815005 | PubTator, text mining | PubMed |
| Molecular and immune landscape of hepatocellular carcinoma for therapeutic development. | J Liver Cancer | 2025 | 39639434 | PubTator, text mining | PubMed |
| Sarsasapogenin stimulates angiogenesis and osteogenesis coupling to treat estrogen deficiency-induced osteoporosis by activating the GPX4/SLIT3/ROBO1 axis. | Phytomedicine | 2025 | 39637471 | PubTator, text mining | PubMed |
| A meta-analysis of genome-wide studies of resilience in the German population. | Mol Psychiatry | 2025 | 39112778 | PubTator, text mining | PubMed |
| Novel susceptibility genes and biomarkers for obstructive sleep apnea: insights from genetic and inflammatory proteins. | Sleep | 2025 | 39087877 | PubTator, text mining | PubMed |
| Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study. | Ann Pediatr Endocrinol Metab | 2024 | 39778407 | PubTator, text mining | PubMed |
| Accelerated growth and local progression of radiorecurrent prostate cancer in an orthotopic bioluminescent mouse model. | Sci Rep | 2024 | 39732766 | PubTator, text mining | PubMed |
| Investigation of Association Between Expression of DYX1C1, KIAA0319, and ROBO1 Genes and Specific Learning Disorder in Children and Adolescents. | J Mol Neurosci | 2024 | 39542997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6091/papers?page=4